The Association Between the Decline of eGFR and a Reduction of Hemoglobin A1c in Type 2 Diabetic Patients

ObjectiveThis study aimed to explore the relationship between short-term (≤12 months) changes in the estimated glomerular filtration rate (eGFR) and hemoglobin A1c (HbA1c) in patients with type 2 diabetes (T2D).MethodA total of 2,599 patients with T2D were enrolled if they were registered in the Dia...

Full description

Bibliographic Details
Main Authors: Lingwang An, Qiuzhi Yu, Linhui Chen, Hong Tang, Yanjun Liu, Qun Yuan, Yu Ji, Yaujiunn Lee, Juming Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.723720/full
_version_ 1798021517633650688
author Lingwang An
Qiuzhi Yu
Linhui Chen
Hong Tang
Yanjun Liu
Qun Yuan
Yu Ji
Yaujiunn Lee
Juming Lu
Juming Lu
author_facet Lingwang An
Qiuzhi Yu
Linhui Chen
Hong Tang
Yanjun Liu
Qun Yuan
Yu Ji
Yaujiunn Lee
Juming Lu
Juming Lu
author_sort Lingwang An
collection DOAJ
description ObjectiveThis study aimed to explore the relationship between short-term (≤12 months) changes in the estimated glomerular filtration rate (eGFR) and hemoglobin A1c (HbA1c) in patients with type 2 diabetes (T2D).MethodA total of 2,599 patients with T2D were enrolled if they were registered in the Diabetes Sharecare Information System, were aged 18–75 years, and had 2–3 HbA1c and eGFR measurements within the preceding 12 months. The studied patients were categorized into five groups based on eGFR, i.e., the relatively stable (RS), fast decline (FD), modest decline (MD), modest increase (MI), and fast increase (FI) groups.ResultsThe median eGFR changes from baseline were −22.14, −6.44, 0.00, 6.32, and 20.00 ml/min per 1.73 m2 for patients in the FD, MD, RS, MI, and FI groups, respectively. Up to 1,153 (44.4%) subjects experienced an eGFR decline of ≥3.5 ml/min per 1.73 m2, including 821 (31.6%) FD subjects and 332 (12.8%) MD subjects. A decreased trend was found between the eGFR change and HbA1c decrease category, even after multivariable adjustment. In general, an eGFR FD was frequently found in patients who had an HbA1c reduction of ≥3.00% and a baseline HbA1c ≥8.0%; alternatively, such a result was also observed for a urinary albumin-to-creatinine ratio (UACR) of 30.0–300.0 mg/g, regardless of a diabetes duration of <10.0 or ≥10.0 years, or in patients who had an HbA1c reduction of ≥1.00% accompanied by hyperfiltration.ConclusionsSome patients with T2D experienced an eGFR FD or MD during the ≤12-month follow-up period. A significant downward trend in eGFR change was demonstrated alongside an HbA1c reduction, independent of UACR stage, diabetes duration, and hyperfiltration. Sustained monitoring and cautious interpretation of the HbA1c and eGFR changes will be needed in clinical practice.
first_indexed 2024-04-11T17:14:54Z
format Article
id doaj.art-89253ed938864ea6b538dcf8c16368ab
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T17:14:54Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-89253ed938864ea6b538dcf8c16368ab2022-12-22T04:12:42ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-01-011210.3389/fendo.2021.723720723720The Association Between the Decline of eGFR and a Reduction of Hemoglobin A1c in Type 2 Diabetic PatientsLingwang An0Qiuzhi Yu1Linhui Chen2Hong Tang3Yanjun Liu4Qun Yuan5Yu Ji6Yaujiunn Lee7Juming Lu8Juming Lu9Department of Endocrinology, Beijing Ruijing Diabetes Hospital, Beijing, ChinaDepartment of Endocrinology, Heilongjiang Ruijing Diabetes Hospital, Haerbin, ChinaDepartment of Endocrinology, Taiyuan Diabetes Hospital, Taiyuan, ChinaDepartment of Share-care Center, Chengdu Ruien Diabetes Hospital, Chengdu, ChinaDepartment of Endocrinology, Lanzhou Ruijing Diabetes Hospital, Lanzhou, ChinaDepartment of Endocrinology, Heilongjiang Ruijing Diabetes Hospital, Haerbin, ChinaDepartment of Endocrinology, Beijing Aerospace General Hospital, Beijing, ChinaLee’s Endocrinology Clinic, Taiwan, ChinaDepartment of Endocrinology, Beijing Ruijing Diabetes Hospital, Beijing, ChinaDepartment of Endocrinology, The General Hospital of the People’s Liberation Army, Beijing, ChinaObjectiveThis study aimed to explore the relationship between short-term (≤12 months) changes in the estimated glomerular filtration rate (eGFR) and hemoglobin A1c (HbA1c) in patients with type 2 diabetes (T2D).MethodA total of 2,599 patients with T2D were enrolled if they were registered in the Diabetes Sharecare Information System, were aged 18–75 years, and had 2–3 HbA1c and eGFR measurements within the preceding 12 months. The studied patients were categorized into five groups based on eGFR, i.e., the relatively stable (RS), fast decline (FD), modest decline (MD), modest increase (MI), and fast increase (FI) groups.ResultsThe median eGFR changes from baseline were −22.14, −6.44, 0.00, 6.32, and 20.00 ml/min per 1.73 m2 for patients in the FD, MD, RS, MI, and FI groups, respectively. Up to 1,153 (44.4%) subjects experienced an eGFR decline of ≥3.5 ml/min per 1.73 m2, including 821 (31.6%) FD subjects and 332 (12.8%) MD subjects. A decreased trend was found between the eGFR change and HbA1c decrease category, even after multivariable adjustment. In general, an eGFR FD was frequently found in patients who had an HbA1c reduction of ≥3.00% and a baseline HbA1c ≥8.0%; alternatively, such a result was also observed for a urinary albumin-to-creatinine ratio (UACR) of 30.0–300.0 mg/g, regardless of a diabetes duration of <10.0 or ≥10.0 years, or in patients who had an HbA1c reduction of ≥1.00% accompanied by hyperfiltration.ConclusionsSome patients with T2D experienced an eGFR FD or MD during the ≤12-month follow-up period. A significant downward trend in eGFR change was demonstrated alongside an HbA1c reduction, independent of UACR stage, diabetes duration, and hyperfiltration. Sustained monitoring and cautious interpretation of the HbA1c and eGFR changes will be needed in clinical practice.https://www.frontiersin.org/articles/10.3389/fendo.2021.723720/fulldiabetestype 2hemoglobin A1c (HbA1c)estimated glomerular filtration rate (eGFR)hyperfiltration
spellingShingle Lingwang An
Qiuzhi Yu
Linhui Chen
Hong Tang
Yanjun Liu
Qun Yuan
Yu Ji
Yaujiunn Lee
Juming Lu
Juming Lu
The Association Between the Decline of eGFR and a Reduction of Hemoglobin A1c in Type 2 Diabetic Patients
Frontiers in Endocrinology
diabetes
type 2
hemoglobin A1c (HbA1c)
estimated glomerular filtration rate (eGFR)
hyperfiltration
title The Association Between the Decline of eGFR and a Reduction of Hemoglobin A1c in Type 2 Diabetic Patients
title_full The Association Between the Decline of eGFR and a Reduction of Hemoglobin A1c in Type 2 Diabetic Patients
title_fullStr The Association Between the Decline of eGFR and a Reduction of Hemoglobin A1c in Type 2 Diabetic Patients
title_full_unstemmed The Association Between the Decline of eGFR and a Reduction of Hemoglobin A1c in Type 2 Diabetic Patients
title_short The Association Between the Decline of eGFR and a Reduction of Hemoglobin A1c in Type 2 Diabetic Patients
title_sort association between the decline of egfr and a reduction of hemoglobin a1c in type 2 diabetic patients
topic diabetes
type 2
hemoglobin A1c (HbA1c)
estimated glomerular filtration rate (eGFR)
hyperfiltration
url https://www.frontiersin.org/articles/10.3389/fendo.2021.723720/full
work_keys_str_mv AT lingwangan theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT qiuzhiyu theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT linhuichen theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT hongtang theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT yanjunliu theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT qunyuan theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT yuji theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT yaujiunnlee theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT juminglu theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT juminglu theassociationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT lingwangan associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT qiuzhiyu associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT linhuichen associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT hongtang associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT yanjunliu associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT qunyuan associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT yuji associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT yaujiunnlee associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT juminglu associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients
AT juminglu associationbetweenthedeclineofegfrandareductionofhemoglobina1cintype2diabeticpatients